Search
Search Results
##search.searchResults.foundPlural##
-
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4120PDF: 1170HTML: 2005Fig.1: 223Fig. 2: 114Table 1: 210Table2: 230Table 3: 206 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2664PDF: 1645HTML: 2376Table1: 201 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3445PDF: 1312HTML: 2234Fi.1 Gritti.Rambaldi: 217 -
Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
2159PDF: 840HTML: 1648Figure 1: 563 -
-
Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature
2055PDF: 940HTML: 1774Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated AML- IMAGES: 178 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4485PDF: 1660HTML: 4100Tables and Images: 247 -
DNA Repair Genes and Chronic Myeloid Leukemia: XPD (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (1394) Gene Polymorphisms Polymorphisms of DNA Repair Genes in CML
1140PDF: 455HTML: 254 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4503PDF: 1747HTML: 1100 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3430PDF: 1503HTML: 4018 -
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1680PDF: 1023HTML: 375 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2690PDF: 973HTML: 3651 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1623PDF: 1001HTML: 209 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1291PDF: 535HTML: 23104 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
2045PDF: 98HTML: 27 -
VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
1276PDF: 665HTML: 7744 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4422PDF: 1785HTML: 1112 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
527PDF: 261HTML: 104 -
-
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2900PDF: 1114HTML: 126 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2052PDF: 827HTML: 229 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2826PDF: 1002HTML: 648 -
IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis
1049PDF: 715HTML: 229 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4613PDF: 1540HTML: 1565Untitled: 243 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3640PDF: 2556HTML: 1525







